|
home | contact us |
![]() |
2007 Symposium Information
Cardiovascular Biomarkers and Surrogate Endpoints Symposium
A Collaborative Approach to Biomarkers
Location: Bethesda North Marriott Hotel & Conference Center, North Bethesda, Maryland
Date: October 17-19, 2007
Objectives:
Welcome
Dear Colleague:
We are pleased to invite you to participate in the 5th Annual Cardiovascular Biomarkers and Surrogate Endpoints Symposium. This outstanding scientific
program addresses current approaches for assessing and managing cardiovascular risk, as well as strategies for advancing the use of biomarkers and innovative
technologies for cardiovascular disorders. We urgently require tools to address the residual burden of cardiovascular
risk that represents a major challenge to human health worldwide. Future biomarker efforts are an integral part of this toolbox and we must
continue to build on knowledge gained from basic research efforts and clinical evaluations, incorporating lessons from past successes and failures. The Cardiovascular
Biomarkers and Surrogate Endpoints Symposium is designed to share knowledge and encourage the collaborative efforts needed to accelerate
the development of improved cardiovascular diagnostics and therapeutic strategies.
Join us to learn how to translate the latest research findings to improve patient healthcare. Presentations from government, academic, industry, and healthcare
thought-leaders will examine the issues surrounding the effective assessment and application of cardiovascular biomarkers and imaging technologies.
Only with your collaboration can
we advance the field of cardiovascular biomarkers and find efficiencies toward improved healthcare.
Sincerely,
| Peter Libby | Jean-Claude Tardif | Therese Heinonen |
| Chief; Cardiology | Director of Research | Associate Director |
| Brigham and Women's Hospital | Montreal Heart Institute | Montreal Heart Institute |
Click for Symposium Agenda
Click for Symposium Faculty
Click for Sponsor Information
Click for Registration